EFDID: 281790EFD: View Filing

Issuer: Olema Pharmaceuticals, Inc. (0001750284) - D

Accession: 0001750284-18-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001750284
  • Entity Name:
    Olema Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    665 3RD STREET SUITE 250
    SAN FRANCISCO, CA 94107
  • Persons:
    Related Persons 9
    Cyrus Harmon
    Executive Officer, Director
    Peter Kusher
    Executive Officer, Director
    Andrew Rappaport
    Director
    Gorjan Hrustanovic
    Director
    Andrei Manoliu
    Director
    Marina Bozilenko
    Director
    Frank McCormick
    Director
    Lawrence Fritz
    Director
    David Myles
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    08/27/2018
  • First Sale Date:
    07/19/2018
  • Offering Amount:
    $6,054,922
  • Amount Sold:
    $6,054,922
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Series A-1 Preferred stock, Series A Preferred Stock, and Common Stock Issuable upon conversion thereof; Common Stock issued upon conversion of promissory notes.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA
Inactive:IL
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Olema Pharmaceuticals, Inc./s/ Cyrus L. HarmanCyrus L. HarmanCEO2018-08-23